Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Maryam Moghaddassi-Jahromi; Mohammad-Ali Sahraian (2011)
Publisher: Zahedan University of Medical Sciences
Journal: Majallah-i taḥqīqāt-i ̒ulūm-i pizishkī-i Zāhidān
Languages: English
Types: Article
Subjects: Connective tissue diseases, lupus erythematosus, antiphospholipid syndrome, demyelination, multiple sclerosis, behcet syndrome, sjogren's syndrome, Medicine, R
Background: Connective tissue diseases (CTD) can involve nervous system. Diagnosis and differentiation from multiple sclerosis (MS) can be difficult especially when the disease presented by symptoms and signs related to demyelinating process. The aim of this article is to review the variant forms of central nervous system involvement in CTD especially useful points for differentiation from demyelinating disorders. Materials and Method: We used the relevant articles in PUBMED, Scopus and other databases especially published in recent ten years. Results: Systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), Behcet’s disease (BD), Sjogren's syndrome (SS), and some vasculitides can involve nervous system. Patients may be present by demyelination areas in the white matter of the brain and spinal cord, which are difficult to differentiate from MS and other demyelinating processes, such as transverse myelitis and optic neuritis. On the other hand, autoantibodies such as antinuclear antibodies (ANA) and antiphospholipid antibodies (aPL) can also occur in MS. Treatment and prognosis of these diseases are quite different. In demyelinating diseases the diagnosis is established on the basis of clinical presentation, magnetic resonance imaging (MRI), cerebrospinal fluid (CSF) examination, visual evoked potentials (VEP) and autoantibody investigation.Conclusion: In many patients, distinction between different etiologies of demyelination can be made by considering clinical and paraclinical data, but in some cases, accurate diagnosis can only be made after long-term follow-up
  • No references.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article

Collected from